DIA
CNMD icon

Dean Investment Associates’s CONMED CNMD Stock Holding History

Dean Investment Associates’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,400
Closed -$1.03M – 194
2025
Q4 		$1.03M Buy
25,400
+4,523
+22% +$197K 0.15% 172
2025
Q3 		$982K Sell
20,877
-7,001
-25% -$363K 0.14% 178
2025
Q2 		$1.45M Sell
27,878
-13,778
-33% -$756K 0.21% 164
2025
Q1 		$2.52M Buy
41,656
+3,709
+10% +$239K 0.37% 132
2024
Q4 		$2.6M Buy
37,947
+12,551
+49% +$875K 0.37% 138
2024
Q3 		$1.83M Sell
25,396
-1,364
-5% -$96.2K 0.25% 170
2024
Q2 		$1.86M Buy
+26,760
New +$1.95M 0.26% 157

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Dean Investment Associates's CNMD Position: Q1 2026 in Review

Dean Investment Associates sold out of CONMED (CNMD) in Q1 2026, closing a stake of 25,400 shares — an estimated $1.03M sold.

Dean Investment Associates first reported a position in CNMD in Q2 2024 and held it in 7 quarters. The position peaked at $2.6M in Q4 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Dean Investment Associates reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Dean Investment Associates sold 25,400 CONMED shares in Q1 2026, an estimated $1.03M.
  • Dean Investment Associates first reported a position in CONMED in Q2 2024 and held it in 7 quarters.
  • Dean Investment Associates's CONMED position peaked at $2.6M in Q4 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.